Comparison of the Anti-Tumour Activity of the Somatostatin Receptor (SST) Antagonist [177Lu]Lu-Satoreotide Tetraxetan and the Agonist [177Lu]Lu-DOTA-TATE in Mice Bearing AR42J SST2-Positive Tumours.
Pharmaceuticals (Basel)
; 15(9)2022 Aug 30.
Article
in En
| MEDLINE
| ID: mdl-36145306
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Pharmaceuticals (Basel)
Year:
2022
Document type:
Article
Affiliation country:
France
Country of publication:
Switzerland